LAMEA Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application (Cloning, Protein Expression, Mutagenesis, and Others), By End-Use, By Country and Growth Forecast, 2024

List of Tables

The Latin America, Middle East and Africa Competent Cells Market would witness market growth of 10.5% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Competent Cells Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $73.9 million by 2031. The Argentina market is showcasing a CAGR of 11.1% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 9.4% during (2024 - 2031).

Emerging these cells market trends reflect ongoing advancements in biotechnology, genetic engineering, and research methodologies. These trends are shaping the future landscape of these cells by introducing new technologies, expanding applications, and addressing industry challenges. For example, adopting advanced gene editing tools, such as CRISPR/Cas systems and base editing technologies, is revolutionizing the market.

Also, there is a growing emphasis on synthetic biology approaches using these cells for metabolic engineering and producing bio-based chemicals, fuels, and pharmaceuticals. Engineered microbial strains with enhanced metabolic pathways and optimized biosynthetic capabilities are being developed to meet sustainability goals and industrial demands.

Expansion in the pharmaceutical sector often leads to increased investments in research and development. According to the National Library of Medicine, Saudi Arabia's pharmaceutical drugs industry is expected to exhibit a growth rate of 7.3% during the forecast period (2020-2027), owing to increasing launches and approval of drugs. Additionally, as the pharmaceutical industry grows in Saudi Arabia, there will be a higher demand for biopharmaceutical products. Brazilian universities and research institutions are pivotal in driving the demand for these cells through their active engagement in biotechnological research and collaborations with industry partners. For instance, Universities such as the University of Sao Paulo (USP), Federal University of Rio de Janeiro (UFRJ), and State University of Campinas (UNICAMP) are leaders in biotechnological research in Brazil. Hence, growing pharmaceutical industry and rising educational and research Institutions are propelling the growth of the market.

Based on Type, the market is segmented into Chemically Competent Cells, Electrocompetent Cells, and Ultracompetent Cells. Based on Application, the market is segmented into Cloning, Protein Expression, Mutagenesis, and Others. Based on End-Use, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Thermo Fisher Scientific, Inc.
Merck KGaA
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Promega Corporation
New England Biolabs, Inc.
Qiagen N.V
F. Hoffmann-La Roche Ltd.
Takara Bio Inc. (Takara Holdings Inc.)
Lonza Group Ltd. (Capsugel)

LAMEA Competent Cells Market Report Segmentation

By Type

Chemically Competent Cells
Electrocompetent Cells
Ultracompetent Cells

By Application

Cloning
Protein Expression
Mutagenesis
Others

By End-Use

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Competent Cells Market, by Type
- 1.4.2 LAMEA Competent Cells Market, by Application
- 1.4.3 LAMEA Competent Cells Market, by End-Use
- 1.4.4 LAMEA Competent Cells Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Strategies Deployed in Competent Cells Market

Chapter 5. LAMEA Competent Cells Market by Type

5.1 LAMEA Chemically Competent Cells Market by Country
5.2 LAMEA Electrocompetent Cells Market by Country
5.3 LAMEA Ultracompetent Cells Market by Country

Chapter 6. LAMEA Competent Cells Market by Application

6.1 LAMEA Cloning Market by Country
6.2 LAMEA Protein Expression Market by Country
6.3 LAMEA Mutagenesis Market by Country
6.4 LAMEA Others Market by Country

Chapter 7. LAMEA Competent Cells Market by End-Use

7.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
7.2 LAMEA Academic & Research Institutes Market by Country
7.3 LAMEA Others Market by Country

Chapter 8. LAMEA Competent Cells Market by Country

8.1 Brazil Competent Cells Market
- 8.1.1 Brazil Competent Cells Market by Type
- 8.1.2 Brazil Competent Cells Market by Application
- 8.1.3 Brazil Competent Cells Market by End-Use
8.2 Argentina Competent Cells Market
- 8.2.1 Argentina Competent Cells Market by Type
- 8.2.2 Argentina Competent Cells Market by Application
- 8.2.3 Argentina Competent Cells Market by End-Use
8.3 UAE Competent Cells Market
- 8.3.1 UAE Competent Cells Market by Type
- 8.3.2 UAE Competent Cells Market by Application
- 8.3.3 UAE Competent Cells Market by End-Use
8.4 Saudi Arabia Competent Cells Market
- 8.4.1 Saudi Arabia Competent Cells Market by Type
- 8.4.2 Saudi Arabia Competent Cells Market by Application
- 8.4.3 Saudi Arabia Competent Cells Market by End-Use
8.5 South Africa Competent Cells Market
- 8.5.1 South Africa Competent Cells Market by Type
- 8.5.2 South Africa Competent Cells Market by Application
- 8.5.3 South Africa Competent Cells Market by End-Use
8.6 Nigeria Competent Cells Market
- 8.6.1 Nigeria Competent Cells Market by Type
- 8.6.2 Nigeria Competent Cells Market by Application
- 8.6.3 Nigeria Competent Cells Market by End-Use
8.7 Rest of LAMEA Competent Cells Market
- 8.7.1 Rest of LAMEA Competent Cells Market by Type
- 8.7.2 Rest of LAMEA Competent Cells Market by Application
- 8.7.3 Rest of LAMEA Competent Cells Market by End-Use

Chapter 9. Company Profiles

9.1 Thermo Fisher Scientific, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
  - 9.1.5.1 Partnerships, Collaborations, and Agreements:
  - 9.1.5.2 Product Launches and Product Expansions:
  - 9.1.5.3 Geographical Expansions:
- 9.1.6 SWOT Analysis
9.2 Merck KGaA
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.6 SWOT Analysis
9.3 Agilent Technologies, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
  - 9.3.5.1 Trail and Approvals:
- 9.3.6 SWOT Analysis
9.4 Bio-Rad laboratories, Inc.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 SWOT Analysis
9.5 Promega Corporation
- 9.5.1 Company Overview
- 9.5.2 Recent strategies and developments:
  - 9.5.2.1 Partnerships, Collaborations, and Agreements:
- 9.5.3 SWOT Analysis
9.6 New England Biolabs, Inc.
- 9.6.1 Company Overview
- 9.6.2 SWOT Analysis
9.7 Qiagen N.V.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 F. Hoffmann-La Roche Ltd.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expense
- 9.8.5 SWOT Analysis
9.9 Takara Bio Inc. (Takara Holdings Inc.)
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expenses
9.10. Lonza Group Ltd. (Capsugel)
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 LAMEA Competent Cells Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Competent Cells Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 4 LAMEA Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 5 LAMEA Chemically Competent Cells Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Chemically Competent Cells Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Electrocompetent Cells Market by Country, 2020 - 2023, USD Million
TABLE 8 LAMEA Electrocompetent Cells Market by Country, 2024 - 2031, USD Million
TABLE 9 LAMEA Ultracompetent Cells Market by Country, 2020 - 2023, USD Million
TABLE 10 LAMEA Ultracompetent Cells Market by Country, 2024 - 2031, USD Million
TABLE 11 LAMEA Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 12 LAMEA Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 13 LAMEA Cloning Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA Cloning Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Protein Expression Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Protein Expression Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Mutagenesis Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Mutagenesis Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 20 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 21 LAMEA Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 22 LAMEA Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 23 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2020 - 2023, USD Million
TABLE 24 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2024 - 2031, USD Million
TABLE 25 LAMEA Academic & Research Institutes Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Academic & Research Institutes Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Competent Cells Market by Country, 2020 - 2023, USD Million
TABLE 30 LAMEA Competent Cells Market by Country, 2024 - 2031, USD Million
TABLE 31 Brazil Competent Cells Market, 2020 - 2023, USD Million
TABLE 32 Brazil Competent Cells Market, 2024 - 2031, USD Million
TABLE 33 Brazil Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 34 Brazil Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 35 Brazil Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 36 Brazil Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 37 Brazil Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 38 Brazil Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 39 Argentina Competent Cells Market, 2020 - 2023, USD Million
TABLE 40 Argentina Competent Cells Market, 2024 - 2031, USD Million
TABLE 41 Argentina Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 42 Argentina Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 43 Argentina Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 44 Argentina Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 45 Argentina Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 46 Argentina Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 47 UAE Competent Cells Market, 2020 - 2023, USD Million
TABLE 48 UAE Competent Cells Market, 2024 - 2031, USD Million
TABLE 49 UAE Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 50 UAE Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 51 UAE Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 52 UAE Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 53 UAE Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 54 UAE Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 55 Saudi Arabia Competent Cells Market, 2020 - 2023, USD Million
TABLE 56 Saudi Arabia Competent Cells Market, 2024 - 2031, USD Million
TABLE 57 Saudi Arabia Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 58 Saudi Arabia Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 59 Saudi Arabia Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 60 Saudi Arabia Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 61 Saudi Arabia Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 62 Saudi Arabia Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 63 South Africa Competent Cells Market, 2020 - 2023, USD Million
TABLE 64 South Africa Competent Cells Market, 2024 - 2031, USD Million
TABLE 65 South Africa Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 66 South Africa Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 67 South Africa Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 68 South Africa Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 69 South Africa Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 70 South Africa Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 71 Nigeria Competent Cells Market, 2020 - 2023, USD Million
TABLE 72 Nigeria Competent Cells Market, 2024 - 2031, USD Million
TABLE 73 Nigeria Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 74 Nigeria Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 75 Nigeria Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 76 Nigeria Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 77 Nigeria Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 78 Nigeria Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 79 Rest of LAMEA Competent Cells Market, 2020 - 2023, USD Million
TABLE 80 Rest of LAMEA Competent Cells Market, 2024 - 2031, USD Million
TABLE 81 Rest of LAMEA Competent Cells Market by Type, 2020 - 2023, USD Million
TABLE 82 Rest of LAMEA Competent Cells Market by Type, 2024 - 2031, USD Million
TABLE 83 Rest of LAMEA Competent Cells Market by Application, 2020 - 2023, USD Million
TABLE 84 Rest of LAMEA Competent Cells Market by Application, 2024 - 2031, USD Million
TABLE 85 Rest of LAMEA Competent Cells Market by End-Use, 2020 - 2023, USD Million
TABLE 86 Rest of LAMEA Competent Cells Market by End-Use, 2024 - 2031, USD Million
TABLE 87 Key Information - Thermo Fisher Scientific, Inc.
TABLE 88 key Information - Merck KGaA
TABLE 89 key Information - Agilent Technologies, Inc.
TABLE 90 Key Information - Bio-Rad Laboratories, Inc.
TABLE 91 key Information - Promega Corporation
TABLE 92 Key Information - New England BioLabs, Inc.
TABLE 93 Key Information - Qiagen N.V.
TABLE 94 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 95 Key Information - Takara Bio Inc.
TABLE 96 Key Information -Lonza Group Ltd.

LAMEA Competent Cells Market Size, Share & Trends Analysis Report By Type, By Application (Cloning, Protein Expression, Mutagenesis, and Others), By End-Use, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents